Browsing Pharmacy Research by Title
Now showing items 253-272 of 1261
-
Correction to: Developing Leadership Skills in Pharmacy Education
( Springer Nature , 2023 , Other)The article “Developing Leadership Skills in Pharmacy Education” was originally published electronically on the publisher’s internet portal on 22 March 2022 with an error in the author group. The family name of the third ... -
Correction to: Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients (Heart Failure Reviews, (2021), 10.1007/s10741-021-10101-0)
( Springer , 2021 , Article)The article “Intermittent levosimendan infusion in ambulatory patients with end‑stage heart failure: a systematic review and meta‑analysis of 984 patients”, written by Hagar Elsherbini, Osama Soliman, Casper Zijderhand, ... -
Correction to: Lead nitrate induces inflammation and apoptosis in rat lungs through the activation of NF‑κB and AhR signaling pathways (Environmental Science and Pollution Research, (2022), 29, 43, (64959-64970), 10.1007/s11356-022-19980-8)
( Springer , 2022 , Article)The sizing of images Figs. 3 and 4 is modified in the original published proof. The Original article has been corrected. -
Corrigendum to "Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study". [Current Problems in Cardiology Volume 46, Issue 6, June 2021, 100816]
( Elsevier , 2021 , Other)Authors regret an affiliation was missed for Dr. Nabil Shallik in the original version. The affiliation "Faculty of Medicine, Tanta University, Tanta, Egypt" has now been added. And also the order of authors has been ... -
Corrigendum: Curcumin-mediated degradation of S-phase kinase protein 2 induces cytotoxic effects in human papillomavirus-positive and negative squamous carcinoma cells(Front. Oncol., (2018), 8, (399), 10.3389/fonc.2018.00399)
( Frontiers Media SA , 2023 , Other)In the published article, there was an error in the Funding statement. The grant number included was incorrect. The original text incorrectly states that "This work was supported by Medical Research Centre (Grant No. RP # ... -
Corrigendum: Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury (BioMed Research International (2017) 2017 (5903105) DOI: 10.1155/2017/5903105)
( Hindawi Limited , 2019 , Other)Following publication of the article, Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury, the authors were made aware that the effects of epalrestat on the high ... -
Cost analysis of medications used in upper respiratory tract infections and prescribing patterns in university sans Malaysia, Penang, Malaysia
( University of Benin , 2014 , Article)Purpose: To conduct a cost analysis, a narrow cost-utility study, for upper respiratory tract infection medications in University Sans Malaysia's clinics. Methods: Retrospective analysis was done for all medical claims of ... -
Cost effectiveness of caspofungin vs. voriconazole for empiric therapy in Turkey
( Blackwell Publishing Ltd , 2014 , Article)Invasive fungal infections from febrile neutropenia are associated with significant cost and mortality. The mainstay of treatment has been liposomal amphotericin B, however, echinocandins and azoles have shown promise as ... -
Cost evaluation of therapeutic drug monitoring of gentamicin at a teaching hospital in Malaysia
( Grupo de Investigacion en Atencion Farmaceutica , 2014 , Article)Background: Therapeutic drug monitoring (TDM) makes use of serum drug concentrations as an adjunct to decision-making. Preliminary data in our hospital showed that approximately one-fifth of all drugs monitored by TDM ... -
Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital
( SAGE , 2023 , Article)Background: The economic benefit of the clinical pharmacist's role in ensuring the optimum use of medicines is potentially considerable, particularly when it comes to cancer management. We sought to evaluate the overall ... -
Cost-benefit analysis of clinical pharmacist intervention in preventing adverse drug events in the general chronic diseases outpatients.
( Wiley , 2019 , Article)Clinical pharmacy services are vital in the prevention of adverse drug events (ADEs) in clinical practice, extending beyond the hospital to chronic disease management in outpatient settings. This study sought to evaluate ... -
Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management
( Elsevier , 2022 , Article)Warfarin is commonly used in thromboembolic conditions. Warfarin interruption represents a significant challenge in pre-operative warfarin management as it is associated with major consequences. Genetics polymorphism ... -
Cost-effectiveness analyses of breast cancer medications use in developing countries: a systematic review
( Taylor and Francis Ltd. , 2020 , Article)Background: Pharmacoeconomics is important for breast-cancer medications due to their high costs. To our knowledge, no systematic literature reviews of pharmacoeconomic studies for breast-cancer medication use are present ... -
Cost-effectiveness analysis of dapagliflozin in addition to standard therapy in heart failure with reduced ejection fraction: A Qatari healthcare perspective
( Hamad bin Khalifa University Press (HBKU Press) , 2022 , Article)Background: Dapagliflozin has been shown to reduce the risk of heart failure hospitalization and cardiovascular mortality in patients with heart failure with reduced ejection fraction (HFrEF). 1,2 This work aims to determine ... -
Cost-effectiveness Analysis of Ibuprofen versus Indomethacin or Paracetamol for the Treatment of Patent Ductus Arteriosus in Preterm Neonates.
( Elsevier , 2023 , Article)This was a first-time evaluation that sought to analyze the cost-effectiveness of oral paracetamol and intravenous (IV) indomethacin as alternatives to ibuprofen for PDA in neonates. Decision-analytic, literature-based, ... -
Cost-Effectiveness Analysis of Out-Of-Hospital versus In-Hospital Extracorporeal Cardiopulmonary Resuscitation for Out-Hospital Refractory Cardiac Arrest
( Elsevier , 2022 , Article)It has been speculated that out-of-hospital cardiac arrest (OHCA) patients’ survival might be improved by implementing extracorporeal cardiopulmonary resuscitation (ECPR) before arrival to hospital. Therefore, we sought ... -
Cost-Effectiveness Analysis of Pharmacist Adherence Interventions in People Living with HIV/AIDS in Pakistan
( MDPI , 2023 , Article)Background: Evidence has shown the positive impact of pharmacist involvement on the adherence and health outcomes of people living with HIV/AIDS. However, whether such intervention provides value for money remains unclear. ... -
Cost-Effectiveness Analysis of Sacubitril/Valsartan for Reducing the Use of Implantable Cardioverter-Defibrillator (ICD) and the Risk of Death in ICD-Eligible Heart Failure Patients with Reduced Ejection Fraction
( Elsevier , 2022 , Article)Although previous cost‐effectiveness evaluations of sacubitril/valsartan have demonstrated cardiovascular and economic benefits in heart failure patients with reduced ejection fraction (HFrEF), whether sacubitril/valsartan ... -
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation
( MDPI , 2022 , Article)Palbociclib and ribociclib are indicated in the first-line treatment of hormonal-receptor-positive HER-2 negative (HR+/HER-2 negative) advanced breast cancer. Despite their clinical benefit, they can increase healthcare ... -
Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review
( SAGE Publications Inc. , 2019 , Article)Venous thromboembolism (VTE) is associated with high recurrence, mortality, and cost burden. Direct oral anticoagulants (DOACs) are currently used for VTE treatment, and they offer more benefits over warfarin, despite being ...